BACE : Lead Target for Orchestrated Therapy of Alzheimer's Disease / Beta-site APP Cleaving Enzyme

BACE : Lead Target for Orchestrated Therapy of Alzheimer's Disease /

BACE inhibitors and their use in the treatment of Alzheimer's Disease. BACE (ß-site of APP cleaving enzyme) is a critical component in Alzheimer's Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE: Lead Target for Orchestrated The...

Full description

Saved in:
Bibliographic Details
Other Authors: John, Varghese, 1958-
Format: Electronic eBook
Language:English
Published: Hoboken, N.J. : John Wiley & Sons, ©2010.
Subjects:
Alzheimer's disease > Chemotherapy.
Aspartic proteinases > Inhibitors > Therapeutic use.
Amyloid beta-protein precursor.
Alzheimer Disease > drug therapy
Amyloid Precursor Protein Secretases > pharmacology
Amyloid Precursor Protein Secretases > therapeutic use
Amyloid beta-Protein Precursor
Online Access: Full text (Emmanuel users only)

Internet

Full text (Emmanuel users only)

Similar Items